Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Rapid decrease in CD8 + T cells following treatment of mice with exogenous corticosterone

Elizabeth C. Bahr and Jodi L. Yorty
Bios
Vol. 84, No. 3 (September 2013), pp. 148-157
Stable URL: http://www.jstor.org/stable/23595288
Page Count: 10
  • Read Online (Free)
  • Download ($6.00)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Rapid decrease in CD8
          +
          T cells following treatment of mice with exogenous corticosterone
Preview not available

Abstract

Corticosterone (CORT) belongs to a family of steroid hormones known as the glucocorticoids. CORT is produced in vivo in response to physical and psychological stress and has immunosuppressive qualities. As an immunosuppressant, CORT alters the frequency of immune cells in lymphoid organs. This study quantified the effects of exogenous CORT on splenic CD8+ T cells in mice. CD8+ T cells are critical for destruction of virally infected and tumorigenic host cells. Thus, it is important to determine the timing by which CORT alters the frequency of CD8+ T cells. CORT was administered in the drinking water of C57BL/6 mice for time intervals ranging from 12-120 hours. Following treatment, spleens were harvested and processed, total splenocytes were counted, and CD8+ T cells were quantified by flow cytometry. Spleens from mice treated with CORT were significantly smaller than spleens from untreated mice following just 12 hours of exposure to CORT. A marked decline in both naïve (CD44lo) and activated (CD44hi) CD8+ T cells was observed. This loss of CD8+ T cells was greater the longer the mice were treated with CORT. Flow cytometric analysis suggests that this decrease in CD8+ T cells was due, in part, to increased amounts of apoptosis in the spleen of CORT treated mice. These studies are important since glucocorticoids are used clinically to suppress unwanted immune responses and to control inflammation and other symptoms associated with radiation and chemotherapy treatments.

Page Thumbnails

  • Thumbnail: Page 
148
    148
  • Thumbnail: Page 
149
    149
  • Thumbnail: Page 
150
    150
  • Thumbnail: Page 
151
    151
  • Thumbnail: Page 
152
    152
  • Thumbnail: Page 
153
    153
  • Thumbnail: Page 
154
    154
  • Thumbnail: Page 
155
    155
  • Thumbnail: Page 
156
    156
  • Thumbnail: Page 
157
    157